a HUSLAB, Helsinki Biobank, Department of Pathology , University of Helsinki and Helsinki University Hospital , Helsinki , Finland.
b Institute for Molecular Medicine Finland (FIMM) , HiLIFE, University of Helsinki , Helsinki , Finland.
Acta Oncol. 2018 Aug;57(8):1109-1116. doi: 10.1080/0284186X.2018.1441543. Epub 2018 Feb 20.
Pulmonary carcinoids (PC) are rare malignant neoplasms that cover approximately 1% of all lung cancers. PCs are classified by histological criteria as either typical (TC) or atypical (AC). Histological subtype is the most studied prognostic factor. The aim of this study was to evaluate if other tissue or clinical features are associated with patient outcomes.
We retrospectively reviewed clinical records of 133 PC patients who underwent operation in the Helsinki University Hospital between 1990 and 2013. Tissue specimens were re-evaluated, processed into tissue microarray format and stained immunohistochemically with serotonin, calcitonin, adrenocorticotropic hormone (ACTH), thyroid transcription factor-1 (TTF-1) and Ki-67. Survival and risk analyses were performed.
Based on histology, 75% (n = 100) of the tumors were TCs and 25% (n = 33) ACs. TCs had higher 10-year disease-specific survival (DSS) rate than ACs (99% (95% CI, 93-100%) for TCs vs. 82% (95% CI, 61-92%) for ACs). Hormonally active tumors expressing serotonin, calcitonin or ACTH were noted in 53% of the specimens but hormonal expression was not associated with DSS. TTF-1 was positive in 78% of the specimens but was not associated with DSS. Ki-67 index varied between <1% and 15%. Ki-67 ≥ 2.5% was associated with shorter DSS (p = .004). The presence of metastatic disease (p = .001), tumor size ≥30 mm (p = .021) and atypical histology (p = .011) were also associated with disease-specific mortality.
We conclude that PCs are uncommon tumors. When resected, the long-term survival is in general favorable. In this consecutive, single-institution cohort of patients, presence of metastatic disease, tumor size, histological subtype and Ki-67 index were associated with shorter disease-specific survival. As TC and AC have different clinical behaviors, the correct tumor classification at the time of diagnosis is a necessity.
肺类癌(PC)是一种罕见的恶性肿瘤,约占所有肺癌的 1%。PC 根据组织学标准分为典型(TC)和非典型(AC)。组织学亚型是研究最多的预后因素。本研究旨在评估其他组织或临床特征是否与患者预后相关。
我们回顾性分析了 1990 年至 2013 年间在赫尔辛基大学医院接受手术的 133 例 PC 患者的临床记录。对组织标本进行重新评估,制成组织微阵列格式,并进行血清素、降钙素、促肾上腺皮质激素(ACTH)、甲状腺转录因子-1(TTF-1)和 Ki-67 的免疫组织化学染色。进行生存和风险分析。
根据组织学,75%(n=100)的肿瘤为 TC,25%(n=33)为 AC。TC 的 10 年疾病特异性生存率(DSS)高于 AC(TC 为 99%(95%CI,93-100%),AC 为 82%(95%CI,61-92%))。在 53%的标本中发现表达血清素、降钙素或 ACTH 的激素活性肿瘤,但激素表达与 DSS 无关。TTF-1 在 78%的标本中阳性,但与 DSS 无关。Ki-67 指数在<1%至 15%之间变化。Ki-67≥2.5%与较短的 DSS 相关(p=0.004)。存在转移性疾病(p=0.001)、肿瘤大小≥30mm(p=0.021)和非典型组织学(p=0.011)也与疾病特异性死亡率相关。
我们得出结论,PC 是罕见的肿瘤。当进行切除时,长期生存通常是有利的。在这个连续的、单机构队列的患者中,存在转移性疾病、肿瘤大小、组织学亚型和 Ki-67 指数与较短的疾病特异性生存相关。由于 TC 和 AC 的临床行为不同,因此在诊断时正确分类肿瘤是必要的。